"List of submitted and published papers &
published abstracts as of March 8, 2010"
Please see below for a list of published papers written by CSRG researchers. A link to the
abstract on PubMed is provided below each citation.
Bernatsky S., Hudson M., Panopalis P., Clarke A.E., Pope J., Leclercq S., St Pierre Y.,
Baron M. and the Canadian Scleroderma Research Group. "The cost of systemic sclerosis." Arthritis Rheum 2009; 61(1): 119-23.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/19116974
Bernatsky S., Hudson M., Pope J., Vinet E., Markland J., Robinson D., Jones N.,
Docherty P., Abu-Hakima M., Leclercq S., Dunne J., Smith D., Mathieu J.P., Khalidi N.,
Sutton E., Baron M. and the Canadian Scleroderma Research Group. "Assessment of reproductive history in systemic sclerosis." Arthritis Rheum 2008; 59(11): 1661-4.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18975360
Bernatsky S., Panopolis P., Hudson M., Pope J., Leclercq S., Robinson D., Jones N.,
Markland J., Abu-Hakima M., Mathieu J.P., Docherty P., Khalidi N., Sutton E., Baron M.
and the Canadian Scleroderma Research Group. "Demographic and clinical factors
associated with physician service use in systemic sclerosis." J Rheumatol 2009; 36(1): 96-8.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/19012361
GaziH., Pope J.E., Clements P., et al."Outcome measurements in scleroderma: results
from a
delphi exercise . "J Rheumatol 2007; 34(3): 501-9.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/17299843
Hudson M., Bernatsky S., Taillefer S., Fortin P.R., Wither J., Baron M., the Canadian
Scleroderma Research Group and the Canadian Network for Improved Outcomes in
Systemic Lupus Erythematosus. "Patients with systemic autoimmune diseases could not
distinguish comorbidities from their index disease.Clin Epidemiol 2008; 61(7): 654-62.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18342489
Hudson M., Rojas-Villarraga A., Coral-Alvarado P., López-Guzmán S., Mantilla R.D.,
Chalem P., the Canadian Scleroderma Research Group, the Colombian Scleroderma
Research Group, Baron M. and Anaya J.M. "Polyautoimmunity and familial autoimmunity
in systemic sclerosis.J Autoimmun 2008; 31(2): 156-9
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18644698
Hudson M., Steele R., Baron M. "Update
on indices of disease activity in systemic sclerosis."
Semin Arthritis Rheum 2007; 37(2): 93-8.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/17363039
Hudson M., Steele R., Lu Y., Thombs BD, Panopalis P, Baron M. "Clinical Correlates of
Self-reported Physical Health Status in Systemic Sclerosis.
" J Rheumatol 2009; Epub ahead of print.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/19447939
Hudson, M., Steele R., Taillefer S., Baron M. and the Canadian
Scleroderma Research
Group (2008). "Quality of life in systemic sclerosis: psychometric properties of Organization
Disease Assessment Schedule II. " Arthritis Rheum 59(2): 270-278.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18240187
Hudson M., Taillefer S., Steele R., et al."Improving the sensitivity of the American College of
Rheumatology classification criteria for systemic sclerosis. "Clin Exp Rheumatol 2007; 25(5):754-7.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18078627
Hudson M., Thombs B., Baron M., and the Canadian Scleroderma Research Group.
"Time to diagnosis in systemic sclerosis: is sex a factor?" Arthritis Rheum 2008; 61(2): 274-278.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/19177534
Hudson M., Thombs B., Steele R., Panopolis P., Newton E., Baron M., and the
Canadian Scleroderma Research Group. "Quality of life in systemic sclerosis compared to the general population and patients with other chronic conditions." J Rheumatol 2009;36(4): 768-72.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/19228662
Hudson, M., Thombs B., Steele R., Watterson R., Taillefer S., Baron M. and the Canadian
Scleroderma Research Group (2008). "Clinical correlates of quality
of life in systemic sclerosis measured with the World Health Organization Disease Assessment Schedule II. " Arthritis
Rheum 59(2): 279-284.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18240196
Hudson M., Walker J.G., Fritzler M., Taillefer S., Baron M. "Hypocomplementemia in systemic
sclerosis--clinical and serological correlations." J Rheumatol 2007; 34(11): 2218-23.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/17937468
Santiago, M., Baron M., Burlingame R., Fritzler M. and the Canadian Scleroderma Research Group
(2007). "Antibodies to RNA polymerase III in systemic sclerosis as detected by an ELISA." J
Rheumatol 34(7): 1528-1534.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/17610318
Thombs, B., Fuss S., Hudson M., Schieir O., Taillefer S., Fogel J., Ford D.E., Baron M. and the
Canadian Scleroderma Research Group (2008). "High rates of depressive symptoms among patients
with systemic sclerosis are not explained by differential reporting of somatic symptoms." Arthritis
Rheum 59(3): 431-437.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18311765
Thombs, B., Hudson M., Schieir O., Taillefer S., Baron M. and the Canadian Scleroderma Research
Group (2008). "Reliability and validity of the Center for Epidemiologic Studies Depression Scale
(CES-D) in patients with systemic sclerosis." Arthritis Rheum 59(3): 438-443.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18311754
Thombs, B., Hudson M., Taillefer S., the Canadian Scleroderma Research Group and Baron M.
(2008). "Prevalence and Clinical Correlates of Symptoms of Depression in Patients with Systemic Sclerosis. "Arthritis Rheum 59(4): 540-509.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18383422
Villela R., Yuen S.Y., Pope J.E., Baron M. and the Canadian Scleroderma Research Group
"Assessment of unmet needs and the lack of generalizability in the design of randomized controlled trials for scleroderma treatment." Arthritis Rheum 2008; 59(5) :706-13.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/18438906
Walker J.G., Pope J., Baron M., et al. The development of systemic sclerosis classification criteria.
Clin Rheumatol 2007; 26(9): 1401-9.
Abstract:http://www.ncbi.nlm.nih.gov/pubmed/17285223
